Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer.

IF 5.6 2区生物学

International Journal of Molecular Sciences Pub Date : 2024-10-09 DOI:10.3390/ijms251910843

Robert G Pergolizzi, Steven T Brower

引用次数: 0

Abstract

Pancreatic cancer is one of the most aggressive and lethal forms of cancer, with a five-year survival rate of less than 10%. Despite advances in treatment modalities, the prognosis for pancreatic cancer patients remains poor, highlighting the urgent need for innovative approaches for early diagnosis and targeted therapies. In recent years, there has been significant progress in understanding the molecular mechanisms underlying pancreatic cancer development and progression. This paper reviews the current knowledge of molecular targets for the diagnosis and treatment of pancreatic cancer.

查看原文本刊更多论文

诊断和治疗胰腺癌的分子靶标。

胰腺癌是最具侵袭性和致命性的癌症之一，五年生存率不到 10%。尽管治疗方法不断进步，但胰腺癌患者的预后仍然很差，这凸显了对早期诊断和靶向治疗创新方法的迫切需求。近年来，人们在了解胰腺癌发生和发展的分子机制方面取得了重大进展。本文回顾了目前对胰腺癌诊断和治疗分子靶点的认识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Molecular Sciences 化学-化学综合

自引率

10.70%

发文量

13472

审稿时长

1.7 months

期刊介绍： The International Journal of Molecular Sciences (ISSN 1422-0067) provides an advanced forum for chemistry, molecular physics (chemical physics and physical chemistry) and molecular biology. It publishes research articles, reviews, communications and short notes. Our aim is to encourage scientists to publish their theoretical and experimental results in as much detail as possible. Therefore, there is no restriction on the length of the papers or the number of electronics supplementary files. For articles with computational results, the full experimental details must be provided so that the results can be reproduced. Electronic files regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material (including animated pictures, videos, interactive Excel sheets, software executables and others).